authors
- Patel, Anand A
- Stock, Wendy
- Segal, Jeremy
- Odenike, Olatoyosi
- Cahill, Kirk
- Charnot-Katsikas, Angella
- Liu, Hongtao
- Gurbuxani, Sandeep
- Thirman, Michael
- Kosuri, Satyajit
- Andrew Artz, MD, MS
- Larson, Richard A
Clinical outcomes of IDH2-mutated advanced-phase Ph-negative myeloproliferative neoplasms treated with enasidenib.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2020
published in
- British journal of haematology Journal